Chromocell Therapeutics
Freehold, US · Founded 2021 · Nevada corporation
Founders & leadership
FK
Francis KnuettelCEO and President, CFO, Treasurer and Secretary
EL
Eric LangChief Medical Officer
Board
EF
Ezra FriedbergBoard director
TD
Todd DavisBoard director
CS
Chia-Lin SimmonsBoard director
RM
Richard MalamutBoard director
Reported raises · per SEC filings
Form D private placements$68.8M disclosed across 3 of 4 rounds · 2024–2025
▶$18MraisedNov 2025 · 8 investors · PharmaceuticalsRule 506(b)
▶$18MraisedNov 2025 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Matthew PaulsDirector
- Peter GreenleafDirector
- Richard BaxterDirector
- Richard MalamutDirector
- Todd DavisDirector
- Francis Knuettel IIExecutive Officer
- Sai RangaraoExecutive Officer
- Scott PleshaExecutive Officer, Director
- Ezra FriedbergDirector
- Offering amount
- $18M
- Amount sold
- $18M
- First sale
- Nov 2025
- Incorporated
- Corporation, Nevada, 2021
- Federal exemptions
- 06b
▶$50.1MraisedJul 2025 · 13 investors · PharmaceuticalsRule 506(b)
▶$50.1MraisedJul 2025 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Matthew PaulsDirector
- Richard MalamutDirector
- Ezra FriedbergDirector
- Scott PleshaExecutive Officer, Director
- Sai RangaraoExecutive Officer
- Peter GreenleafDirector
- Francis Knuettel IIExecutive Officer
- Todd DavisDirector
- Richard BaxterDirector
- Offering amount
- $50.1M
- Amount sold
- $50.1M
- First sale
- Jul 2025
- Incorporated
- Corporation, Nevada, 2021
- Federal exemptions
- 06b
▶$30MofferedAug 2024 · 1 investors · PharmaceuticalsRule 506(b)
▶$30MofferedAug 2024 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ezra FriedbergDirector
- Chia-Lin SimmonsDirector
- Richard MalamutDirector
- Francis KnuettelExecutive Officer
- Eric LangExecutive Officer
- Todd DavisDirector
- Offering amount
- $30M
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$750KraisedAug 2024 · 1 investors · PharmaceuticalsRule 506(b)
▶$750KraisedAug 2024 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Francis KnuettelExecutive Officer
- Todd DavisDirector
- Ezra FriedbergDirector
- Richard MalamutDirector
- Chia-Lin SimmonsDirector
- Eric LangExecutive Officer
- Offering amount
- $750K
- Amount sold
- $750K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Chromocell Therapeutics raised?
- Chromocell Therapeutics has disclosed $68.8M raised across 3 of its 4 known rounds.
- Where is Chromocell Therapeutics headquartered?
- Chromocell Therapeutics is headquartered in Freehold, US.